New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors
Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies
Zevalin Regimen Better Than Rituximab Alone For NHL
SWOG Trial Reports Longest Survival To Date For NSCLC
Two Drugs Slow Progress Of Metastatic Prostate Cancer
New Ultrasound Technique For Hard To Diagnose Cysts
NCI-Approved Clinical Trials Listed For May 2001
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









